tiprankstipranks
Advertisement
Advertisement
Perseus Proteomics Extends Clinical Trial for ANKL Treatment
PremiumCompany AnnouncementsPerseus Proteomics Extends Clinical Trial for ANKL Treatment
5M ago
Perseus Proteomics Reports Q2 Financial Results Amid Ongoing Challenges
Premium
Company Announcements
Perseus Proteomics Reports Q2 Financial Results Amid Ongoing Challenges
5M ago
Perseus Proteomics and ASKA Pharmaceutical Collaborate on Novel Antibody Drugs
Premium
Company Announcements
Perseus Proteomics and ASKA Pharmaceutical Collaborate on Novel Antibody Drugs
5M ago
Perseus Proteomics Reports Fiscal Year 2025 Financial Results Amid Uncertainty
PremiumCompany AnnouncementsPerseus Proteomics Reports Fiscal Year 2025 Financial Results Amid Uncertainty
11M ago
Perseus Proteomics Releases FY2025 Business Forecasts Amid Licensing Challenges
Premium
Company Announcements
Perseus Proteomics Releases FY2025 Business Forecasts Amid Licensing Challenges
1y ago
Perseus Proteomics Completes Phase I Trial Report for PPMX-T003
Premium
Company Announcements
Perseus Proteomics Completes Phase I Trial Report for PPMX-T003
1y ago
Perseus Proteomics Extends Clinical Trial for Rare Leukemia
PremiumCompany AnnouncementsPerseus Proteomics Extends Clinical Trial for Rare Leukemia
1y ago
Perseus Proteomics Reports Promising Trial Results
Premium
Company Announcements
Perseus Proteomics Reports Promising Trial Results
1y ago
Perseus Proteomics Faces Mixed Financial Results
Premium
Company Announcements
Perseus Proteomics Faces Mixed Financial Results
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100